An Anthem prior authorization denial is almost always a decision issued by AIM Specialty Health (now Carelon Medical Benefits Management) using proprietary imaging or specialty criteria. Those criteria diverge — often sharply — from the nationally recognized ACR Appropriateness Criteria that radiologists themselves rely on. An Anthem PA appeal that quotes the correct ACR recommendation and shows where Carelon departs from it typically forces the issue onto defensible ground Anthem prefers not to defend.
This guide is the specific playbook for a Anthem Blue Cross Blue Shield prior authorization denial — Anthem's 2025 CMS intermediate sanctions, the $315M emergency-care class settlement, and AIM/Carelon's divergence from ACR Appropriateness Criteria are the backdrop. What follows: the documented reasons Anthem issues this category of denial, what federal and state law actually require Anthem to do, the written appeal step by step, the evidence to gather, and the deadlines that control the whole process. Every statistic is sourced to KFF, CMS, HHS OIG, published court filings, or Anthem's own public disclosures.